Universe Pharmaceuticals (UPC) Non-Current Assets (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Non-Current Assets data on file, last reported at $15.7 billion in Q3 2025.

• For the quarter ending Q3 2025, Non-Current Assets fell 3.77% year-over-year to $15.7 billion; the trailing twelve-month figure through Sep 2025 stood at $15.7 billion (down 3.77% YoY), and the FY2025 full-year result was $15.7 billion, down 3.77% from the prior year.
• Non-Current Assets fell to $15.7 billion in Q3 2025, from $16.3 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $16.3 billion in Q3 2024 to a low of $15.9 million in Q1 2024.
• A 5-year average of $4.0 billion and a median of $18.8 million in 2021 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets tumbled 100.0% in 2021 and surged 99054.25% in 2024, its largest moves.
• Tracing UPC's Non-Current Assets over 5 years: stood at $19.7 million in 2021, then declined by 8.29% to $18.0 million in 2022, then fell by 8.76% to $16.5 million in 2023, then surged by 99054.25% to $16.3 billion in 2024, then slipped by 3.77% to $15.7 billion in 2025.
• Business Quant data shows UPC's Non-Current Assets at $15.7 billion in Q3 2025, $16.3 billion in Q3 2024, and $15.9 million in Q1 2024.